Cargando…
Difficulties in demonstrating long term immunity in FeLV vaccinated cats due to increasing age-related resistance to infection
BACKGROUND: Feline leukaemia virus (FeLV) is a pathogen causing fatal illness in cats worldwide, and as such there is a high demand for products to protect against disease. The duration of immunity provided by an inactivated FeLV vaccine, Versifel FeLV, when administered to cats of the target age wa...
Autores principales: | Wilson, Stephen, Greenslade, Juliet, Saunders, Gillian, Holcroft, Catherine, Bruce, Lynn, Scobey, Andy, Childers, Tedd, Sture, Gordon, Thompson, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433334/ https://www.ncbi.nlm.nih.gov/pubmed/22839692 http://dx.doi.org/10.1186/1746-6148-8-125 |
Ejemplares similares
-
Acute monoblastic leukemia in a FeLV-positive cat
por: Prihirunkit, Kreangsak, et al.
Publicado: (2008) -
Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection
por: Major, Andrea, et al.
Publicado: (2009) -
Diseases associated with spontaneous feline leukemia virus (FeLV) infection in cats
por: Reinacher, M.
Publicado: (1989) -
Comparative measurement of FeLV load in hemolymphatic tissues of cats with hematologic cytopenias
por: Abdollahi-Pirbazari, Mehdi, et al.
Publicado: (2019) -
Comparative efficacy of the Leucofeligen™ FeLV/RCP and Purevax™ RCP FeLV vaccines against infection with circulating feline Calicivirus
por: Almeras, T., et al.
Publicado: (2017)